News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Photo collage of Laura Bukavina and Phillip Abbosh
Jul 4, 2024, 13:06

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:

“The NTACT residual disease test, eloquently presented by Phillip Abbosh published in JCO Precision Oncology. Remarkably, over 50% of patients without visible residual disease had positive mutations, indicative of field cancerization—mutations present in adjacent normal tissue WITHOUT cancer. NTACT demonstrated 91% sensitivity and 82% accuracy.”

Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh

Read further.
Source: Laura Bukavina/X

cancer cancer mutations Cleveland Clinic field cancerization JCO Precision Oncology Laura Bukavina NTACT OncoDaily Oncology oncology research Phillip Abbosh Precision Medicine residual disease test Urologic Oncologist
Special Coverage
Blog
Dec 19, 2024, 17:20
Registration open for Multidisciplinary Management of Breast Cancer Course - ESTRO
Science
Dec 19, 2024, 17:13
Using ‘Biological Age’ to Predict Early Colorectal Cancer Risk - Sylvester Comprehensive Cancer Center
Blog
Dec 19, 2024, 17:09
Lisa A. Lacasse: Urgent call to pass the MCED Act for multi-cancer detection
Blog
Dec 19, 2024, 17:08
Breakthroughs in cancer research give families more time together - Canadian Cancer Society
Blog
Dec 19, 2024, 17:05
Juan W. Valle: ESMO updates BTC guidelines for advanced care
Blog
Dec 19, 2024, 17:04
UCLA at SABCS 2024: Advancing Breast Cancer Research in Survival, Genomics, and Disparities
Blog
Dec 19, 2024, 17:01
Emily Kobayashi: Mongolia becomes the 144th country to introduce the HPV vaccine
Blog
Dec 19, 2024, 16:53
Giuseppe Curigliano: Great pleasure to host Prof. Humaid Al-Shamsi
Blog
Dec 19, 2024, 16:50
Arif Kamal: Reaching out can make all the difference for loved ones with cancer
Blog
Dec 19, 2024, 16:42
Registration for the 2025 ASCO Annual Meeting is officially open!
Blog
Dec 19, 2024, 16:41
Survival after trimodal therapy in organ-confined bladder cancer
Blog
Dec 19, 2024, 16:20
Monica Bertagnolli: New policy to accelerate access to NIH-funded research results